Fundraising Fox

Seraxis

Germantown, US · Founded 2021 · 2 known investors

seraxis.com ↗

Seraxis is a regenerative medicine company developing a replacement cell therapy for insulin-dependent (Type 1) diabetes, using engineered islet cells to replace those missing in patients. It pursues scientific collaborations and licensing partnerships around its cell therapy technologies.

BiotechHealthtechin /seraxis@qodeinteractive

Founders & leadership

GY
Gi-Hyeok YangDirector
CW
Carole WelschExecutive Officer
WL
William L. RustExecutive Officer, Director, Promoter
RA
Roy ArupDirector
BT
Bernie TreidlDirector
JN
James N. TopperDirector

Investors · 2

Maryland TEDCOUpper Marlboro · $500K – $1.5M
Frazier Life SciencesreportedPalo Alto

Reported raises · per SEC filings

Form D private placements
▶$14MraisedFeb 2021 · 5 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Gi-Hyeok YangDirector
  • James N. TopperDirector
  • Carole WelschExecutive Officer
  • William L. RustExecutive Officer, Director, Promoter
  • Roy ArupDirector
  • Bernie TreidlDirector
Offering amount
$40M
Amount sold
$14M
Finders' fees
$849.5K
Placement agents
Capstone Headwaters
First sale
Jan 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.